Both Breitling and Glycine have been acquired in recent weeks, Glycine by Invicta, and Breitline by CVC, a private equity firm. It’s interesting, because usually venture capital wants a 10x return on investment, and they seek out companies whose only limitation on growth is money on hand.
Direct MP3 Download • The HourTime Show on iTunes • RSS Feed • Listen on Stitcher
Thank you for reading this WristWatchReview post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
WristWatchReview is one of the few remaining truly independent watch news outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent watch sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis. We don't play the games the other sites play and we've paid for it when it comes to ad revenue.
We would love for you to support us on Patreon and every little bit helps. Thank you.
–The WWR Team